Consumer Defensive
BIOHARVEST SCIENCES INC.(CNVCF)
Live Price
Offline$3.31
-2.07% today
1Y Change
-50.23%
Window
Jun 25, 2025 โ Jun 16, 2026
- Market Cap
- $100.00M
- Revenue Growth
- +130.5%
- EPS Growth
- -8.1%
- Dividend Yield
- 0.0%
Coverage: 245 bars ยท Jun 25, 2025 โ Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
BIOHARVEST SCIENCES INC. (CNVCF) is a Consumer Defensive stock with a market cap of $100.00M and listed on NASDAQ. The stock last traded around $3.31 and down 50.2% across the available one-year price window (Jun 25, 2025 โ Jun 16, 2026). Baseline metrics include revenue growth of +130.5%, EPS growth of -8.1%, a dividend yield of 0.0%. What stands out right now is revenue +130.5%, EPS -8.1%, free cash flow +4.8% with operating margin -27.7% and ROIC -45.3%. Valuation sits in the middle of the pack at price/sales 4.0. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines CNVCF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+130.5% vs +1.7% peer median
Operating Margin
Below sector median
-27.7% vs +6.6% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2025 was reported on Aug 27, 2025, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +130.5% and EPS is at -8.1%, with operating margin around -27.7%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -1.5% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2025 Aug 27, 2025 | โ | -5.2% | -9.4% | +31.0% |
2025 May 28, 2025 | โ | +2.3% | +2.5% | +18.0% |
2024 Nov 14, 2024 | -142.4% | +2.3% | +2.5% | +18.0% |
Benchmark Edge
CNVCF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
CNVCF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
CNVCF Max Drawdown
-76.13%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for CNVCF and SPY.
Company Overview
BIOHARVEST SCIENCES INC.
NASDAQ
BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness products. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes. The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.
- Street Address
- 1140-625 Howe Street
- Mailing
- Vancouver, BC, V6C 2T6
- Region
- Vancouver, BC, Canada
- Last Updated
- May 8, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 4.0
- Price/Book
- 71.1
Growth
- Revenue
- +130.5%
- EPS
- -8.1%
- Free Cash Flow
- +4.8%
Profitability
- Gross Margin
- 55.4%
- Operating Margin
- -27.7%
- Net Margin
- -51.3%
- ROE
- 191.0%
- ROIC
- -45.3%
Balance Sheet
- Debt/Equity
- 10.39
- Current Ratio
- 0.55
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.